<DOC>
	<DOCNO>NCT00238160</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , fluorouracil cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving drug directly artery around tumor may kill tumor cell . Giving chemotherapy surgery may kill remain tumor cell . It yet know whether surgery hepatic arterial chemotherapy effective surgery alone treat patient liver cancer spread portal vein . PURPOSE : This randomized phase III trial study surgery hepatic arterial chemotherapy see well work compare surgery alone treat patient liver cancer spread portal vein .</brief_summary>
	<brief_title>Surgery With Without Hepatic Arterial Chemotherapy Treating Patients With Liver Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy surgical resection v without postoperative hepatic arterial chemotherapy patient hepatocellular carcinoma portal vein tumor thrombus . OUTLINE : This randomize , multicenter study . Patients stratify accord grade portal invasion Child-Pugh classification . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo macroscopic curative resection . Within 28 day surgery , patient without post-surgery complication undergo hepatic arterial infusion comprise fluorouracil cisplatin day 1-5 , 8-12 , 15-19 . Treatment continue 6 month . - Arm II : Patients undergo macroscopic curative resection . PROJECTED ACCRUAL : A total 100 patient ( 50 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm hepatocellular carcinoma ( HCC ) portal vein tumor thrombus Tumor thrombus main trunk first branch portal vein No apparent distant metastases chest CT scan bone scintigraphy within past 6 week No pleural effusion ascites PATIENT CHARACTERISTICS : Age Not specify Performance status ECOG 01 Life expectancy Not specify Hematopoietic Neutrophil count &gt; 1,000/mm^3 Platelet count &gt; 50,000/mm^3 Hemoglobin &gt; 8 g/dL Hepatic Bilirubin &lt; 2 time upper limit normal ( ULN ) ALT AST &lt; 4 time ULN Renal Creatinine normal Cardiovascular No severe heart disease No cardiac effusion Other No malignant disease No high risk esophageal varix rupture No allergy fluorouracil cisplatin PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior hepatic arterial chemotherapy No prior systemic chemotherapy HCC Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>